Published by
@ShahidNShah
@ShahidNShah
The 5th Optimizing Hybrid Clinical Trials Summit 2024 convenes stakeholders in Clinical Operations, Innovation, Procurement, and Digital Health to address challenges in conducting successful hybrid trials. Key topics include building budget and financial business cases, ensuring end-to-end data flow, and maintaining data integrity. Participants will gain practical insights on financial strategies, data quality enhancement through electronic capture, and leveraging digital solutions to reduce patient burden. This event, attended by senior stakeholders from leading pharmaceutical companies like Pfizer, Bayer, Eli Lilly and Co, among others, aims to optimize hybrid clinical trials, enhance diversity, equity, and inclusion (DE&I), and improve operational efficiency.
[Read on optimizing-hybrid-clinical-trials](https://optimizing-hybrid-clinical-trials.com/take-part/register/)
Continue reading at optimizing-hybrid-clinical-trials.com
September 11 to September 12, 2024
Hilton Rochester Mayo Clinic Area, 10 East Center Street, Rochester, Minnesota, 55904, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 6, 2024 at 12:08pm